Exova Group Plc (EXO) Rating Reiterated by Credit Suisse Group AG
Exova Group Plc (LON:EXO)‘s stock had its “outperform” rating reaffirmed by equities researchers at Credit Suisse Group AG in a note issued to investors on Thursday. They currently have a GBX 220 ($2.75) price objective on the stock. Credit Suisse Group AG’s price objective would suggest a potential upside of 18.28% from the company’s current price.
EXO has been the topic of a number of other reports. Barclays PLC reiterated an “overweight” rating and issued a GBX 225 ($2.81) price objective on shares of Exova Group Plc in a research report on Thursday, September 1st. Peel Hunt reiterated an “add” rating and issued a GBX 210 ($2.62) price objective on shares of Exova Group Plc in a research report on Wednesday, September 21st. Shore Capital reiterated a “buy” rating on shares of Exova Group Plc in a research report on Thursday. Finally, Goldman Sachs Group Inc. lowered their price objective on shares of Exova Group Plc from GBX 219 ($2.74) to GBX 210 ($2.62) and set a “buy” rating on the stock in a research report on Thursday, September 1st. One analyst has rated the stock with a hold rating and five have issued a buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average price target of GBX 223 ($2.79).
Shares of Exova Group Plc (LON:EXO) opened at 185.80 on Thursday. Exova Group Plc has a one year low of GBX 123.00 and a one year high of GBX 215.00. The company has a 50 day moving average of GBX 199.23 and a 200-day moving average of GBX 192.52. The stock’s market cap is GBX 465.24 million.
The firm also recently announced a dividend, which was paid on Wednesday, November 9th. Shareholders of record on Thursday, October 27th were issued a GBX 1.05 ($0.01) dividend. This represents a yield of 0.53%. The ex-dividend date of this dividend was Thursday, October 27th.
Exova Group Plc Company Profile
Exova Group plc is a United Kingdom-based provider of testing and advisory services. The Company is a laboratory-based testing company operating approximately 140 laboratories and offices in over 30 countries throughout Europe, the Americas, the Middle East and Asia/Asia Pacific. The Company’s segments include Europe, Americas and Rest of World.
Receive News & Stock Ratings for Exova Group Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exova Group Plc and related stocks with our FREE daily email newsletter.